Hyoscyamine, atropine, scopolamine, and phenobarbital vs CYP2C8 Substrates (High risk)

Interacting Drugs
Hyoscyamine, atropine, scopolamine, and phenobarbital
vs
CYP2C8 Substrates (High risk)
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C8 Substrates (High risk): CYP2C8 Inducers (Highly Effective) may increase the metabolism of CYP2C8 Substrates (High risk).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs CYP2C8 Substrates (High risk)


Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital

We are Developing Our database, More results coming soon.

Other Interactions of CYP2C8 Substrates (High risk)

We are Developing Our database, More results coming soon.